U.S. markets open in 5 hours 51 minutes

Cellectar Biosciences, Inc. (CLRB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.4100+0.0100 (+0.71%)
At close: 4:00PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
0
0
0
-
-
Operating Expense
14,507
14,179
11,655
13,601
9,450
Operating Income
-14,507
-14,179
-11,655
-13,601
-9,450
Net Non Operating Interest Income Expense
31.588
42.712
29.687
16.605
7.897
Other Income Expense
-
43
-1,613
22.075
3,262
Pretax Income
-14,429
-14,093
-13,239
-13,562
-6,180
Net Income Common Stockholders
-14,429
-14,093
-15,481
-15,011
-6,180
Diluted NI Available to Com Stockholders
-14,429
-14,093
-15,481
-15,011
-6,180
Basic EPS
-
-0.0018
-0.0052
-0.0107
-0.0136
Diluted EPS
-
-0.0018
-0.0052
-0.0107
-0.0136
Basic Average Shares
-
7,675
2,962
1,403
453.656
Diluted Average Shares
-
7,675
2,962
1,403
453.656
Total Operating Income as Reported
-14,507
-14,179
-13,331
-13,601
-9,450
Total Expenses
14,507
14,179
11,655
13,601
9,450
Net Income from Continuing & Discontinued Operation
-14,429
-14,093
-13,239
-13,562
-6,180
Normalized Income
-14,429
-14,136
-11,626
-13,584
-9,442
Net Interest Income
31.588
42.712
29.687
16.605
7.897
EBIT
-14,507
-14,179
-11,655
-13,601
-9,450
EBITDA
-14,373
-
-
-
-
Reconciled Depreciation
134.001
132.798
82.265
1,546
356.665
Net Income from Continuing Operation Net Minority Interest
-14,429
-14,093
-13,239
-13,562
-6,180
Total Unusual Items Excluding Goodwill
-
43
-1,613
22.075
3,262
Total Unusual Items
-
43
-1,613
22.075
3,262
Normalized EBITDA
-14,373
-14,089
-9,960
-12,077
-12,355
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0